137 related articles for article (PubMed ID: 3263597)
1. [Use of T-activin and prodigiozan in combined treatment of patients with diabetic retinopathy].
Sakalo EA; Malyzhev VA; Danilova AI
Oftalmol Zh; 1988; (4):204-7. PubMed ID: 3263597
[No Abstract] [Full Text] [Related]
2. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
Shilov VA; Shirinskiĭ VS
Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
[No Abstract] [Full Text] [Related]
3. [Use of prodigiozan and tactivin for treatment of patients with chronic Klebsiella infections].
Titov LP; Shaban ZhG; Kartel' AI
Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):46-9. PubMed ID: 11871301
[TBL] [Abstract][Full Text] [Related]
4. [Clinico-pathogenetic substantiation of the immunocorrective treatment of pyelonephritis in infants].
Kirillov VI
Pediatriia; 1990; (2):24-31. PubMed ID: 2349036
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of levamisole, prodigiozan and diucifon in the treatment of acute pneumonia].
Sil'vestrov VP; Karaulov AV; Likov VF
Ter Arkh; 1983; 55(12):56-61. PubMed ID: 6665720
[No Abstract] [Full Text] [Related]
6. [Immunocorrection with T-activin in the combined treatment of juvenile rheumatoid arthritis].
Melikhova NI; Kuz'mina NN; Chirkin VV; Arion VIa; Baryshkov IuA
Revmatologiia (Mosk); 1987; (3):19-23. PubMed ID: 3317708
[No Abstract] [Full Text] [Related]
7. [Prodigiozan in the complex treatment of respiratory tract sarcoidosis].
Daurov BI; Poletaev SD; Stefani DV
Klin Med (Mosk); 1982 Sep; 60(9):90-3. PubMed ID: 6983627
[No Abstract] [Full Text] [Related]
8. [Various aspects of immunomodulating therapy in patients with protracted pneumonia during convalescence].
Karaulov AV; Martsinovskiĭ VIu; Khvatalin IV; Khromenkov IuI; Plakhov IV
Ter Arkh; 1986; 58(4):113-7. PubMed ID: 3487131
[No Abstract] [Full Text] [Related]
9. [Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators].
Khomenko IS; Chukanov VI; Gergert VIa; Utkin VV
Probl Tuberk; 1990; (1):24-8. PubMed ID: 2336431
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
Batian AN; Abramovskaia AK; Batian ON
Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
[TBL] [Abstract][Full Text] [Related]
11. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
Karachunskiĭ MA; Gergert VIa; Iakovleva OB
Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
[TBL] [Abstract][Full Text] [Related]
12. [The effect of stimulants of immunity on anti-infective resistance and on the activity of the liver monooxygenase system].
Sibiriak SV; Alekhin EK; Khaĭbullina SF; Riabchinskaia LA
Farmakol Toksikol; 1990; 53(2):55-7. PubMed ID: 2369957
[TBL] [Abstract][Full Text] [Related]
13. [Systemic autoantibodies and their correction in patients with diabetic retinopathy in type 1 diabetes mellitus].
Teplinskaia LE; Vetrov IuD
Vestn Oftalmol; 2006; 122(6):29-33. PubMed ID: 17217199
[TBL] [Abstract][Full Text] [Related]
14. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of prodigiozan in the complex treatment of erysipelas].
Frolov VM; Rychnev VE
Klin Med (Mosk); 1984 Aug; 62(8):123-6. PubMed ID: 6387266
[No Abstract] [Full Text] [Related]
16. [Clinical-immunological and ecological research in diabetic retinopathy].
Stukalov SE; Shchepetneva MA; Kornienko VN
Vestn Oftalmol; 2004; 120(1):36-9. PubMed ID: 15017777
[TBL] [Abstract][Full Text] [Related]
17. [Immunostimulators in the complex treatment of acute pneumonia].
Men'kov NV
Sov Med; 1985; (3):85-8. PubMed ID: 4023842
[No Abstract] [Full Text] [Related]
18. [The intraperitoneal administration of chemical preparations and taktivin in the combined treatment of stomach cancer].
Shchepotin IB; Chernyĭ VA; Grinevich IuA; Kamenets LIa; Osinskiĭ SP
Vrach Delo; 1988 Sep; (9):3-6. PubMed ID: 3212989
[No Abstract] [Full Text] [Related]
19. [Use of immunostimulators in the treatment of inflammatory processes in the maxillofacial region].
Starodubtsev VS; Biberman IaM; Shaĭdullin MS; Kostishin ID
Voen Med Zh; 1986 Feb; (2):49-50. PubMed ID: 3705481
[No Abstract] [Full Text] [Related]
20. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
